Literature DB >> 6831346

Respiratory failure due to pulmonary leukostasis following chemotherapy of acute nonlymphocytic leukemia.

T J Myers, S R Cole, A U Klatsky, D H Hild.   

Abstract

Four patients with acute nonlymphocytic leukemia and leukocyte counts of more than 200,000/mm3 developed respiratory distress due to pulmonary leukostasis within 10-48 hours after initiation of chemotherapy. Clinically, the patients manifested fever, dyspnea, tachypnea, diffuse pulmonary rales, pleural effusions, and severe hypoxemia. Chest roentgenograms displayed diffuse pulmonary infiltrates, vascular engorgement, cardiomegaly, and pleural effusions. Three patients died from progressive respiratory failure despite ventilatory support. Pulmonary histology revealed thrombi composed of leukemic blast cells which obstructed and distended the lumens of pulmonary arterioles, capillaries, and venules. Electron microscopy studies of lung tissue showed pulmonary alveolar endothelium and basement membrane damage and interstitial edema. The pathophysiologic basis of pulmonary leukostasis and potential treatment modalities are discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6831346     DOI: 10.1002/1097-0142(19830515)51:10<1808::aid-cncr2820511009>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host.

Authors:  C Mayaud; J Cadranel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  Lysis pneumonopathy associated with the use of fludarabine phosphate.

Authors:  J J Crowley; L Knight; N Charan
Journal:  West J Med       Date:  1994-12

3.  Leucostasis, an underestimated cause of death in leukaemia.

Authors:  M A van Buchem; J te Velde; R Willemze; P J Spaander
Journal:  Blut       Date:  1988-01

4.  Chemotherapy exposure increases leukemia cell stiffness.

Authors:  Wilbur A Lam; Michael J Rosenbluth; Daniel A Fletcher
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.